Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04260217
Brief Title: APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (MAPLE-1)

First Submitted : February 5, 2020
First Submitted that Met QC Criteria : February 5, 2020
First Posted : February 7, 2020

Last Update Submitted that Met QC Criteria : July 8, 2021
Last Update Posted : July 12, 2021